Malignant neoplasm of prostate – Page 3

MacroGenics Reviews Safety Protocols Following Three Patient Deaths in Prostate Cancer Drug Trial

1 year ago talkbio0Tagged Antibodies, Bispecific, Cessation of life, MacroGenics, Malignant neoplasm of prostate, margetuximab, Phase 2 trial, safety review

MacroGenics, Phase 2 trial, prostate cancer, patient deaths, safety review, margetuximab, bispecific antibody

Expansion of Pluvicto Use Sought by Novartis Following Positive Prostate Cancer Study Update

2 years ago talkbio0Tagged Malignant neoplasm of prostate, Metastatic castration-resistant prostate cancer, Novartis, Pluvicto, Progression-Free Survival, PSMAfore trial, Radiographic, rPFS

Novartis, Pluvicto, Broader use, Prostate cancer, PSMAfore trial, Radiographic progression-free survival (rPFS), Metastatic castration-resistant prostate cancer (mCRPC)

Janux Shares Surge Over 200% on Promising Early Signs of PSA Response in Prostate Cancer Treatment

2 years ago talkbio0Tagged Janux, JANX007, Malignant neoplasm of prostate, Prostate-Specific Antigen

Prostate-Specific Antigen, Janux, JANX007, Malignant neoplasm of prostate